Last checked at 24 Dec 2019 08:01
Creo Medical Group plc
("Creo" or the "Company")
Director / PDMR Shareholding
Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces that following Admission of the New Ordinary Shares today, Charles Spicer, Non-Executive Chairman and David Woods, Non-Executive Director, have purchased 13,800 and 25,000 Ordinary Shares respectively in the Fundraising, at the Issue Price of 180 pence per Ordinary Share. Following these purchases, Charles Spicer and David Woods hold 93,810 and 25,000 Ordinary Shares respectively.
Capitalised terms used, but not defined in this announcement shall have the same meaning as set out in the Circular.
The information below, set out in accordance with the requirements of the MAR, provides further detail.
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | 1. Charles Spicer 2. David Woods | |||
2 | Reason for the notification | ||||
a) | Position/status | 1. Non-Executive Chairman 2. Non-Executive Director | |||
b)
| Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Creo Medical Group plc | |||
b) | LEI | 213800H188ZDCWWXFA21 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of £0.001 each | |||
|
| ||||
Identification code | GB00BZ1BLL44 | ||||
|
| ||||
b) | Nature of the transaction | Purchase of shares | |||
c)
| Price(s) and volume(s) |
|
|
|
|
|
| Price(s) | Volume(s) |
| |
|
| 1. 180p 2. 180p | 1. 13,800 2. 25,000 |
| |
|
|
|
|
| |
d) | Aggregated information |
| |||
|
| ||||
- Aggregated volume | N/A - single transaction | ||||
|
| ||||
- Price |
| ||||
|
| ||||
e) | Date of the transaction | 24 December 2019 | |||
f) | Place of the transaction | London Stock Exchange | |||